Canadian startup Aux Labs is a new player in the animal-free dairy space with what it describes as a more flexible approach to product development and scale that reflects the strained funding environment.
The company recently raised $4 million in a round led by NYA Ventures and Nàdarra Ventures, with a focus on commercializing its precision fermentation platform for dairy proteins.
Designing an ingredient to work within existing fermentation infrastructure
Aux Labs’ key differentiator in the alternative protein space lies in its approach to manufacturing and scale.
Instead of designing the ingredient first and then figuring out how to produce at scale, the startup looked to existing manufacturing infrastructure to inform its ingredient design.
“We thought about what manufacturing and scale looked like first, and then we then tuned our engineering strategy to that end,” Ted Jin, CEO and founder of Aux Labs said.
As part of that strategy, Aux Labs is using existing brewing facilities in North America to scale rather than building its own production plant – a capital drain plaguing many startups trying to commercialize fermentation infrastructure in the current funding environment.
“We have been leveraging existing brewing capacity in order for us to get production,” he said. “Rather than build out a lot of these bespoke systems, we’re trying to utilize more traditional fermentation capacity in order for us to actually scale.”
Perfecting animal-free mozzarella performance
Via precision fermentation, Aux Labs produces casein, which is the key protein in cheese. It joins the category alongside other casein-producers like Better Dairy and New Culture.
“We produce real casein proteins that serve as the foundation for cheese so that it can perform exactly the way consumers expect dairy to perform,” Jin said.
Mozzarella is commonly explored by animal-free dairy companies given its organoleptic challenges to melt and stretch like its conventional counterpart – and Aux Labs intends to perfect its performance.
While the dairy industry is facing critical headwinds from economic and climate factors, it’s product performance, not sustainability that will drive consumer adoption, Jin emphasized.
“Performance is the decisive factor,” he said. “If it doesn’t deliver at the end of the day, they’re not going to come back.”
This focus on performance reflects what Jin describes as lessons from earlier waves of alternative protein companies.
“We’re drawing from a lot of the category’s past failures,” he said, pointing to issues around product positioning, launch strategy and consumer education that hindered growth and adoption.
Biotech startups can’t rely on one ingredient – they need platforms that scale
From an investor perspective, Nàdarra Ventures viewed Aux Labs as part of a broader shift in both the dairy industry and biotechnology.
“For really the first time in history, the global dairy system is under extreme pressure,” said Mary Dimou, managing partner at Nàdarra Ventures, citing climate stress, herd health and constrained production.
Dimou pointed to progress in fermentation and biotech which are enabling a new class of companies.
“We’re seeing biology used as a programmable production system for proteins, ingredients, materials and even functional compounds,” Dimou said.
Aux Labs stood out not just because of its focus on cheese, but because of its underlying platform that extends beyond dairy and into additional proteins, giving it the nimbleness to adapt to different market needs.
“Aux Labs is more than just a dairy company,” she said. “There’s this underlying protein platform itself, which is highly flexible. It’s not a single category company.”
Another factor in the investment was the company’s ability to integrate into existing infrastructure.
“The real selling point for us was just how it could integrate into really existing infrastructure, like craft breweries,” Dimou said.
‘Food tech is going through a very meaningful reset right now’
Aux Lab’s funding also reflects a broader reset in the food-tech sector. Both Jin and Dimou pointed to a tighter funding environment compared to previous years.
Dimou described the current moment as a shift toward more efficient, execution-focused companies.
“Food tech is going through a very meaningful reset right now,” she said. “They need to explain to investors really what a realistic commercialization pathway is.”
At the seed stage, she added, capital limitations are forcing companies to rethink how they scale.
“At the seed stage of investment, it’s an absolute necessity” to use existing infrastructure, otherwise startups will struggle to build a credible product, she said.
Dairy-free cheese is ‘not just for vegans’
Aux Labs’ commercialization strategy reflects those constraints, with a focus on partnerships and real-world applications rather than a narrow launch strategy.
“We are focused on the right partner,” Jin said, adding that routes to market could include foodservice, retail or CPG partnerships.
He also emphasized Aux Lab’s animal-free cheese is not limited to a niche consumer base.
“It was not just for vegans … the majority just wanted to try it” during tasting events the company hosted, he said.
Ultimately, the company is prioritizing three core factors that will drive mainstream adoption.
“The factors that matter here are taste, function and price,” Jin said. “Those are non-negotiables these days.”
While Aux Labs believes it has addressed taste and functionality, the startup’s focus on price parity to conventional cheese is a work in progress.
Reformulation triggers the next wave of ingredients
For Dimou, Aux Labs fits into what she sees as the next phase of value creation in the alternative protein space: ingredients rather than finished products.
“It’s an ingredient-by-ingredient basis,” she said, noting that this shift aligns with larger CPG companies increasingly focusing on reformulation to achieve cleaner labels, Dimou said.
“It allows the larger corporate … to build up a new SKU with your one ingredient versus an end product,” she explained.
That shift may make it easier for startups to integrate into existing product pipelines and scale more quickly, she added.
